In an interview with USA Today, Lauren Friedlander, MD, discusses the FDA's new requirements that providers inform patients about their breast density during mammograms.
Breast density awareness is linked to heightened uncertainty about cancer risk and screening choices among Spanish-speaking women in Northern Manhattan, according to a study led by Parisa Tehranifar.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
While medical experts agree that women should all get screened, the age at which screening should begin is an area of controversy, leaving patients confused as to what they should do.
Nearly half of all women have dense breasts. But many are not aware that having dense breasts comes with an elevated risk of breast cancer and that they could benefit from additional imaging tests.
Elaine Alden shares her story of overcoming triple-negative breast cancer with the hope of helping and supporting other patients and their families who are affected by cancer.
Researchers from the Herbert Irving Comprehensive Cancer Center presented new research on breast cancer risk prediction at the 2021 San Antonio Breast Cancer Symposium.
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
Desiree Walker is dedicated to patient advocacy, driving awareness, community outreach engagement, empowering cancer patients, and linking them to the resources they need during treatment and beyond.